The Ensign Group, Inc. (ENSG) 10-Year Financial Performance & Capital Metrics

ENSG •

HealthcareHealthcare FacilitiesPost-acute and senior care

AboutThe Ensign Group, Inc. provides health care services in the post-acute care continuum and other ancillary businesses. The company operates in two segments, Skilled Services and Real Estate. The company offers skilled services, which include short and long-term nursing care services for patients with chronic conditions, prolonged illness, and the elderly; and physical, occupational, and speech therapies and other rehabilitative and healthcare services. It also provides standard services, such as room and board, special nutritional programs, social, recreational, entertainment, and other services. In addition, the company offers senior living, as well as mobile diagnostics services; leases real estate properties; and provides other ancillary services consisting of digital x-ray, ultrasound, electrocardiogram, laboratory, sub-acute, and patient transportation services to people in their homes or at long-term care facilities. As of April 4, 2022, it operated 252 healthcare facilities in Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Texas, Utah, Washington, and Wisconsin. The company was incorporated in 1999 and is based in San Juan Capistrano, California.Show more

Revenue $5.06B +18.7%
EBITDA $530M +19.7%
Net Income $344M +15.4%
EPS (Diluted) 5.84 +14.1%
Gross Margin 20.54% +31.1%
EBITDA Margin 10.47% +0.8%
Operating Margin 8.41%
Net Margin 6.8% -2.8%
ROE 16.88% -5.5%
ROIC 8.92% +3.1%
Debt/Equity 0.93 -13.7%
Interest Coverage -

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Strong 5Y profit CAGR of 15.1%
✓Strong Piotroski F-Score: 7/9
✓12 consecutive years of dividend growth
✓High quality earnings: Operating CF exceeds net income
✓Strong 5Y sales CAGR of 16.1%
✓Good 3Y average ROE of 16.7%

✗Weaknesses

No significant weaknesses identified

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y14.19%

5Y16.05%

3Y18.68%

TTM17.54%

Profit (Net Income) CAGR

10Y20.03%

5Y15.07%

3Y15.25%

TTM36.76%

EPS CAGR

10Y18.61%

5Y13.8%

3Y13.92%

TTM35.35%

ROCE

10Y Avg9.95%

5Y Avg10.27%

3Y Avg9.28%

Latest10.01%

Peer Comparison

Post-acute and senior care

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
PNTGThe Pennant Group, Inc.	1.18B	33.71	40.13	36.31%	3.12%	7.9%	4.11%	1.21
ENSGThe Ensign Group, Inc.	12.4B	214.17	36.67	18.72%	6.8%	15.46%	2.99%	0.93
NHCNational HealthCare Corporation	2.54B	163.50	21.32	13.23%	6.75%	9.57%	5.86%	0.08
EHCEncompass Health Corporation	10.79B	107.88	19.44	10.46%	9.33%	16.98%		0.08
SEMSelect Medical Holdings Corporation	1.85B	14.97	12.91	5.12%	2.8%	5.47%	20.65%	0.51
BKDBrookdale Senior Living Inc.	3.64B	15.30	-13.66	7.29%	-8.21%	-308.45%	5.99%
SNDASonida Senior Living, Inc.	681.62M	35.89	-66.46	19.19%	-12.39%	-53.82%		5.03

Profit & Loss

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Sales/Revenue+	1.65B	1.6B	1.75B	2.04B	2.4B	2.63B	3.03B	3.73B	4.26B	5.06B
Revenue Growth %	23.33%	-3.42%	9.78%	16.07%	17.98%	9.36%	15.15%	23.27%	14.24%	18.72%
Cost of Goods Sold+	1.47B	1.43B	1.54B	1.75B	2B	2.16B	2.51B	3.14B	3.59B	4.02B
COGS % of Revenue	88.61%	89.18%	87.54%	85.71%	83.04%	82.18%	82.88%	84.16%	84.33%	79.46%
Gross Profit+	188.47M	172.9M	218.68M	291.11M	407.47M	468.21M	517.99M	590.76M	667.59M	1.04B
Gross Margin %	11.39%	10.82%	12.46%	14.29%	16.96%	17.82%	17.12%	15.84%	15.67%	20.54%
Gross Profit Growth %	1.68%	-8.26%	26.48%	33.12%	39.97%	14.91%	10.63%	14.05%	13%	55.6%
Operating Expenses+	96.62M	129.71M	133.76M	161.93M	184.31M	207.75M	221.16M	335.39M	309.28M	269.82M
OpEx % of Revenue	5.84%	8.12%	7.62%	7.95%	7.67%	7.91%	7.31%	8.99%	7.26%	5.33%
Selling, General & Admin	69.17M	74.12M	90.56M	110.87M	129.74M	151.76M	158.81M	263M	225.14M	269.82M
SG&A % of Revenue	4.18%	4.64%	5.16%	5.44%	5.4%	5.78%	5.25%	7.05%	5.28%	5.33%
Research & Development	0	0	0	0	0	0	0	0	0	0
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	27.46M	55.59M	43.2M	51.05M	54.57M	55.98M	62.35M	72.39M	84.14M	0
Operating Income+	91.85M	43.19M	84.91M	129.18M	223.16M	260.46M	296.82M	255.37M	358.3M	425.31M
Operating Margin %	5.55%	2.7%	4.84%	6.34%	9.29%	9.91%	9.81%	6.85%	8.41%	8.41%
Operating Income Growth %	-1.33%	-52.98%	96.62%	52.13%	72.75%	16.72%	13.96%	-13.97%	40.31%	18.7%
EBITDA+	130.53M	87.66M	129.78M	180.23M	277.73M	316.45M	359.18M	327.75M	442.44M	529.63M
EBITDA Margin %	7.89%	5.48%	7.4%	8.85%	11.56%	12.04%	11.87%	8.79%	10.38%	10.47%
EBITDA Growth %	7.7%	-32.84%	48.05%	38.88%	54.09%	13.94%	13.5%	-8.75%	34.99%	19.71%
D&A (Non-Cash Add-back)	38.68M	44.47M	44.86M	51.05M	54.57M	55.98M	62.35M	72.39M	84.14M	104.33M
EBIT	92.95M	44.8M	86.93M	131.83M	226.97M	264.85M	298.02M	280.85M	394.38M	0
Net Interest Income+	-6.03M	-12.01M	-13.17M	-13.01M	-5.55M	-2.46M	-3.9M	11.13M	20.46M	0
Interest Income	1.11M	1.61M	2.02M	2.65M	3.81M	4.39M	5.04M	19.22M	28.75M	24.51M
Interest Expense	7.14M	13.62M	15.18M	15.66M	9.36M	6.85M	8.93M	8.09M	8.29M	-7.99M
Other Income/Expense	-6.03M	-12.01M	-13.17M	-13.01M	-5.55M	-2.46M	-7.74M	17.39M	27.79M	30.32M
Pretax Income+	85.82M	31.18M	71.75M	116.17M	217.61M	258M	289.09M	272.76M	386.09M	455.62M
Pretax Margin %	5.19%	1.95%	4.09%	5.7%	9.06%	9.82%	9.56%	7.31%	9.06%	9.01%
Income Tax+	32.98M	14.21M	12.69M	23.95M	46.24M	60.28M	64.44M	62.91M	87.64M	111.36M
Effective Tax Rate %	58.25%	129.81%	128.74%	95.15%	78.34%	75.45%	77.72%	76.77%	77.18%	75.49%
Net Income+	49.99M	40.48M	92.36M	110.53M	170.48M	194.65M	224.68M	209.4M	297.97M	343.97M
Net Margin %	3.02%	2.53%	5.26%	5.43%	7.1%	7.41%	7.43%	5.61%	6.99%	6.8%
Net Income Growth %	-9.82%	-19.03%	128.2%	19.67%	54.23%	14.18%	15.43%	-6.8%	42.3%	15.44%
Net Income (Continuing)	52.84M	16.97M	59.06M	92.21M	171.36M	197.72M	224.65M	209.85M	298.46M	344.26M
Discontinued Operations	0	23.7M	32.87M	18.84M	0	0	0	0	0	0
Minority Interest	4.05M	7.66M	11.4M	1.95M	150K	946K	1.47M	5.45M	3.32M	3.1M
EPS (Diluted)+	0.96	0.77	1.70	1.97	3.06	3.42	3.95	3.65	5.12	5.84
EPS Growth %	-9.43%	-19.79%	120.78%	15.88%	55.33%	11.76%	15.5%	-7.59%	40.27%	14.06%
EPS (Basic)	0.99	0.79	1.78	2.07	3.19	3.57	4.09	3.76	5.26	6.00
Diluted Shares Outstanding	52.13M	52.83M	54.4M	55.98M	55.79M	56.92M	56.87M	57.32M	58.24M	58.87M
Basic Shares Outstanding	50.55M	50.93M	52.02M	53.45M	53.43M	54.49M	54.89M	55.71M	56.66M	57.31M
Dividend Payout Ratio	16.35%	21.54%	10.2%	9.22%	6.35%	5.93%	5.42%	6.16%	4.59%	-

Balance Sheet

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Current Assets+	333.86M	368.08M	348.07M	411.08M	582.96M	639.71M	781.13M	1.05B	1.16B	1.27B
Cash & Short-Term Investments	69.26M	55.43M	39.77M	76.93M	250.01M	275.96M	331.71M	526.86M	526.85M	503.88M
Cash Only	57.71M	42.34M	31.08M	59.17M	236.56M	262.2M	316.27M	509.63M	464.6M	503.88M
Short-Term Investments	11.55M	13.09M	8.68M	17.75M	13.45M	13.76M	15.44M	17.23M	62.26M	0
Accounts Receivable	244.43M	265.07M	251.91M	308.99M	305.06M	328.73M	408.43M	485.04M	569.9M	636.99M
Days Sales Outstanding	53.91	60.53	52.4	55.38	46.34	45.67	49.27	47.47	48.82	45.97
Inventory	0	0	0	0	0	0	0	0	0	0
Days Inventory Outstanding	-	-	-	-	-	-	-	-	-	-
Other Current Assets	0	0	30.64M	0	0	29.56M	36.34M	35.04M	60.88M	131.44M
Total Non-Current Assets+	667.16M	734.36M	833.89M	1.95B	1.96B	2.21B	2.67B	3.13B	3.51B	4.19B
Property, Plant & Equipment	484.5M	537.08M	618.87M	1.81B	1.8B	2.03B	2.44B	2.85B	3.15B	3.79B
Fixed Asset Turnover	3.42x	2.98x	2.84x	1.12x	1.33x	1.30x	1.24x	1.31x	1.35x	1.33x
Goodwill	67.1M	81.06M	80.48M	54.47M	54.47M	60.47M	76.87M	76.87M	97.98M	97.98M
Intangible Assets	54.66M	58.05M	58.6M	6.45M	6.62M	6.38M	6.44M	6.53M	7.29M	6.38M
Long-Term Investments	0	0	0	0	0	0	0	0	0	166.84M
Other Non-Current Assets	37.83M	45.41M	130.75M	70.83M	65.36M	83.61M	104.94M	132.89M	187.75M	41.6M
Total Assets+	1B	1.1B	1.18B	2.36B	2.55B	2.85B	3.45B	4.18B	4.67B	5.46B
Asset Turnover	1.65x	1.45x	1.48x	0.86x	0.94x	0.92x	0.88x	0.89x	0.91x	0.93x
Asset Growth %	33.87%	10.13%	7.21%	99.83%	7.78%	11.98%	21.1%	21.02%	11.77%	17%
Total Current Liabilities+	211.93M	225.82M	269.23M	343.17M	562.4M	523.07M	582.07M	734.75M	743.43M	894.35M
Accounts Payable	38.99M	39.04M	39.85M	44.97M	50.9M	58.12M	77.09M	92.81M	98.95M	97.33M
Days Payables Outstanding	9.71	10	9.47	9.4	9.31	9.82	11.22	10.79	10.05	8.84
Short-Term Debt	8.13M	9.94M	10.11M	2.7M	2.96M	3.76M	3.88M	3.95M	4.09M	119.04M
Deferred Revenue (Current)	13.09M	13.64M	7.31M	10.69M	8.56M	9.34M	9.7M	10.83M	18.82M	0
Other Current Liabilities	1.97M	0	30.25M	0	102.02M	0	0	0	0	677.98M
Current Ratio	1.58x	1.63x	1.29x	1.20x	1.04x	1.22x	1.34x	1.42x	1.56x	1.42x
Quick Ratio	1.58x	1.63x	1.29x	1.20x	1.04x	1.22x	1.34x	1.42x	1.56x	1.42x
Cash Conversion Cycle	-	-	-	-	-	-	-	-	-	-
Total Non-Current Liabilities+	328.6M	376.55M	310.39M	1.36B	1.16B	1.31B	1.62B	1.95B	2.09B	2.33B
Long-Term Debt	275.49M	302.99M	233.13M	325.22M	112.54M	152.88M	149.27M	145.5M	141.59M	1.95B
Capital Lease Obligations	0	0	0	973.98M	950.32M	1.06B	1.36B	1.64B	1.74B	0
Deferred Tax Liabilities	0	0	0	0	0	0	0	0	0	0
Other Non-Current Liabilities	53.12M	61.49M	65.84M	63.39M	102.09M	96.44M	116.77M	160.65M	208.59M	384.59M
Total Liabilities	540.53M	602.37M	579.62M	1.71B	1.73B	1.83B	2.2B	2.68B	2.83B	3.23B
Total Debt+	283.62M	312.93M	243.24M	1.35B	1.11B	1.27B	1.57B	1.87B	1.97B	2.07B
Net Debt	225.91M	270.59M	212.16M	1.29B	877.45M	1B	1.26B	1.36B	1.51B	1.56B
Debt / Equity	0.62x	0.63x	0.40x	2.05x	1.36x	1.24x	1.26x	1.25x	1.07x	0.93x
Debt / EBITDA	2.17x	3.57x	1.87x	7.47x	4.01x	4.00x	4.38x	5.71x	4.46x	3.91x
Net Debt / EBITDA	1.73x	3.09x	1.63x	7.14x	3.16x	3.17x	3.50x	4.15x	3.41x	2.95x
Interest Coverage	12.87x	3.17x	5.59x	8.25x	23.84x	38.03x	33.24x	31.58x	43.24x	-
Total Equity+	460.5M	500.06M	602.34M	656.14M	818.23M	1.02B	1.25B	1.5B	1.84B	2.23B
Equity Growth %	7.85%	8.59%	20.45%	8.93%	24.7%	24.87%	22.23%	19.9%	22.92%	21.43%
Book Value per Share	8.83	9.47	11.07	11.72	14.67	17.95	21.96	26.12	31.60	37.96
Total Shareholders' Equity	456.45M	492.4M	590.93M	654.2M	818.08M	1.02B	1.25B	1.49B	1.84B	2.23B
Common Stock	52K	53K	55K	56K	58K	58K	59K	60K	61K	62K
Retained Earnings	235.02M	264.69M	344.9M	391.52M	551.05M	733.99M	946.34M	1.14B	1.43B	1.76B
Treasury Stock	-31.12M	-38.41M	-38.41M	-45.3M	-71.21M	-83.04M	-114.63M	-116.56M	-117.76M	0
Accumulated OCI	0	0	0	0	0	0	0	0	0	0
Minority Interest	4.05M	7.66M	11.4M	1.95M	150K	946K	1.47M	5.45M	3.32M	3.1M

Cash Flow

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Cash from Operations+	73.89M	72.95M	210.3M	192.22M	373.35M	275.68M	272.51M	376.67M	347.19M	564.27M
Operating CF Margin %	4.46%	4.56%	11.99%	9.44%	15.54%	10.49%	9.01%	10.1%	8.15%	11.16%
Operating CF Growth %	121.43%	-1.27%	188.27%	-8.6%	94.23%	-26.16%	-1.15%	38.22%	-7.83%	62.53%
Net Income	52.84M	40.83M	92.53M	111.69M	171.36M	197.72M	224.65M	209.85M	298.46M	344.26M
Depreciation & Amortization	38.68M	44.47M	47.34M	51.05M	54.57M	55.98M	62.35M	72.39M	84.14M	104.33M
Stock-Based Compensation	9.1M	9.7M	10.34M	11.32M	14.52M	18.68M	22.72M	30.77M	36.23M	48.3M
Deferred Taxes	-2.21M	10.33M	1.09M	3.49M	-27.81M	-24.88M	-6.5M	-27.48M	635K	-16.86M
Other Non-Cash Items	7.72M	32.51M	25.04M	10.72M	11.65M	28.14M	6.23M	53.25M	2.89M	84.24M
Working Capital Changes	-32.25M	-64.88M	33.96M	3.95M	149.05M	33K	-36.94M	37.89M	-75.16M	0
Change in Receivables	-63.62M	-52.3M	-13.1M	-60.42M	2.17M	-30.77M	-82.43M	-79.82M	-84.4M	-70.43M
Change in Inventory	30.3M	-9.8M	44.01M	55.62M	0	0	0	0	0	0
Change in Payables	577K	3.33M	3.08M	4.46M	6.63M	7.12M	17.87M	15.92M	2.83M	-2.92M
Cash from Investing+	-210.64M	-106.59M	-151.21M	-247.01M	-58.67M	-173.91M	-186.18M	-182.7M	-390.05M	-513.18M
Capital Expenditures	-65.7M	-54.08M	-135.62M	-71.54M	-50.33M	-69.55M	-87.55M	-106.18M	-158.24M	-193.56M
CapEx % of Revenue	3.97%	3.38%	7.73%	3.51%	2.09%	2.65%	2.89%	2.85%	3.71%	3.83%
Acquisitions	-23.58M	-77.51M	-4.72M	-6.46M	47.55M	-7.98M	-16.4M	0	0	0
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	-121.36M	23.41M	-526K	-165.54M	-58.67M	-91.6M	-74.62M	-64.55M	-153.06M	-308.57M
Cash from Financing+	152.88M	18.27M	-70.34M	82.88M	-137.3M	-76.14M	-32.26M	-612K	-2.16M	-11.81M
Debt Issued (Net)	184.49M	31.86M	-69.94M	83.35M	-212.54M	42.16M	-3.69M	-3.88M	-3.95M	0
Equity Issued (Net)	-1000K	-1000K	0	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K	0
Dividends Paid	-8.17M	-8.72M	-9.42M	-10.19M	-10.83M	-11.55M	-12.17M	-12.89M	-13.67M	-14.41M
Share Repurchases	-30M	-7.29M	-1.97M	-6.89M	-25.92M	-11.83M	-31.58M	-1.93M	-1.21M	-1.43M
Other Financing	6.57M	2.42M	9.01M	16.62M	111.99M	-94.92M	2.51M	18.09M	16.67M	2.6M
Net Change in Cash	16.14M	-15.37M	-11.25M	28.09M	177.39M	25.64M	54.07M	193.36M	-45.03M	39.28M
Free Cash Flow+	8.19M	15.79M	155.35M	120.68M	323.02M	206.13M	184.97M	270.49M	188.95M	370.71M
FCF Margin %	0.49%	0.99%	8.85%	5.93%	13.44%	7.85%	6.11%	7.25%	4.43%	7.33%
FCF Growth %	130.73%	92.77%	884.13%	-22.32%	167.67%	-36.19%	-10.27%	46.23%	-30.15%	96.2%
FCF per Share	0.16	0.30	2.86	2.16	5.79	3.62	3.25	4.72	3.24	6.30
FCF Conversion (FCF/Net Income)	1.48x	1.80x	2.28x	1.74x	2.19x	1.42x	1.21x	1.80x	1.17x	1.64x
Interest Paid	6.43M	13.28M	15.99M	0	9.92M	5.69M	7.6M	7.03M	7.06M	0
Taxes Paid	23.16M	38.38M	19.65M	0	74.36M	65.55M	70.06M	89.73M	96.34M	0

Key Ratios

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Return on Equity (ROE)	11.27%	8.43%	16.76%	17.57%	23.13%	21.16%	19.79%	15.25%	17.85%	16.88%
Return on Invested Capital (ROIC)	11.76%	4.45%	8.04%	7.02%	9.2%	10.5%	9.83%	7.14%	8.66%	8.92%
Gross Margin	11.39%	10.82%	12.46%	14.29%	16.96%	17.82%	17.12%	15.84%	15.67%	20.54%
Net Margin	3.02%	2.53%	5.26%	5.43%	7.1%	7.41%	7.43%	5.61%	6.99%	6.8%
Debt / Equity	0.62x	0.63x	0.40x	2.05x	1.36x	1.24x	1.26x	1.25x	1.07x	0.93x
Interest Coverage	12.87x	3.17x	5.59x	8.25x	23.84x	38.03x	33.24x	31.58x	43.24x	-
FCF Conversion	1.48x	1.80x	2.28x	1.74x	2.19x	1.42x	1.21x	1.80x	1.17x	1.64x
Revenue Growth	23.33%	-3.42%	9.78%	16.07%	17.98%	9.36%	15.15%	23.27%	14.24%	18.72%

US Stock Screener

...

The Ensign Group, Inc. (ENSG) 10-Year Financial Performance & Capital Metrics

ENSG •

HealthcareHealthcare FacilitiesPost-acute and senior care

Revenue $5.06B +18.7%
EBITDA $530M +19.7%
Net Income $344M +15.4%
EPS (Diluted) 5.84 +14.1%
Gross Margin 20.54% +31.1%
EBITDA Margin 10.47% +0.8%
Operating Margin 8.41%
Net Margin 6.8% -2.8%
ROE 16.88% -5.5%
ROIC 8.92% +3.1%
Debt/Equity 0.93 -13.7%
Interest Coverage -

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Strong 5Y profit CAGR of 15.1%
✓Strong Piotroski F-Score: 7/9
✓12 consecutive years of dividend growth
✓High quality earnings: Operating CF exceeds net income
✓Strong 5Y sales CAGR of 16.1%
✓Good 3Y average ROE of 16.7%

✗Weaknesses

No significant weaknesses identified

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y14.19%

5Y16.05%

3Y18.68%

TTM17.54%

Profit (Net Income) CAGR

10Y20.03%

5Y15.07%

3Y15.25%

TTM36.76%

EPS CAGR

10Y18.61%

5Y13.8%

3Y13.92%

TTM35.35%

ROCE

10Y Avg9.95%

5Y Avg10.27%

3Y Avg9.28%

Latest10.01%

Peer Comparison

Post-acute and senior care

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
PNTGThe Pennant Group, Inc.	1.18B	33.71	40.13	36.31%	3.12%	7.9%	4.11%	1.21
ENSGThe Ensign Group, Inc.	12.4B	214.17	36.67	18.72%	6.8%	15.46%	2.99%	0.93
NHCNational HealthCare Corporation	2.54B	163.50	21.32	13.23%	6.75%	9.57%	5.86%	0.08
EHCEncompass Health Corporation	10.79B	107.88	19.44	10.46%	9.33%	16.98%		0.08
SEMSelect Medical Holdings Corporation	1.85B	14.97	12.91	5.12%	2.8%	5.47%	20.65%	0.51
BKDBrookdale Senior Living Inc.	3.64B	15.30	-13.66	7.29%	-8.21%	-308.45%	5.99%
SNDASonida Senior Living, Inc.	681.62M	35.89	-66.46	19.19%	-12.39%	-53.82%		5.03

Profit & Loss

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Sales/Revenue+	1.65B	1.6B	1.75B	2.04B	2.4B	2.63B	3.03B	3.73B	4.26B	5.06B
Revenue Growth %	23.33%	-3.42%	9.78%	16.07%	17.98%	9.36%	15.15%	23.27%	14.24%	18.72%
Cost of Goods Sold+	1.47B	1.43B	1.54B	1.75B	2B	2.16B	2.51B	3.14B	3.59B	4.02B
COGS % of Revenue	88.61%	89.18%	87.54%	85.71%	83.04%	82.18%	82.88%	84.16%	84.33%	79.46%
Gross Profit+	188.47M	172.9M	218.68M	291.11M	407.47M	468.21M	517.99M	590.76M	667.59M	1.04B
Gross Margin %	11.39%	10.82%	12.46%	14.29%	16.96%	17.82%	17.12%	15.84%	15.67%	20.54%
Gross Profit Growth %	1.68%	-8.26%	26.48%	33.12%	39.97%	14.91%	10.63%	14.05%	13%	55.6%
Operating Expenses+	96.62M	129.71M	133.76M	161.93M	184.31M	207.75M	221.16M	335.39M	309.28M	269.82M
OpEx % of Revenue	5.84%	8.12%	7.62%	7.95%	7.67%	7.91%	7.31%	8.99%	7.26%	5.33%
Selling, General & Admin	69.17M	74.12M	90.56M	110.87M	129.74M	151.76M	158.81M	263M	225.14M	269.82M
SG&A % of Revenue	4.18%	4.64%	5.16%	5.44%	5.4%	5.78%	5.25%	7.05%	5.28%	5.33%
Research & Development	0	0	0	0	0	0	0	0	0	0
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	27.46M	55.59M	43.2M	51.05M	54.57M	55.98M	62.35M	72.39M	84.14M	0
Operating Income+	91.85M	43.19M	84.91M	129.18M	223.16M	260.46M	296.82M	255.37M	358.3M	425.31M
Operating Margin %	5.55%	2.7%	4.84%	6.34%	9.29%	9.91%	9.81%	6.85%	8.41%	8.41%
Operating Income Growth %	-1.33%	-52.98%	96.62%	52.13%	72.75%	16.72%	13.96%	-13.97%	40.31%	18.7%
EBITDA+	130.53M	87.66M	129.78M	180.23M	277.73M	316.45M	359.18M	327.75M	442.44M	529.63M
EBITDA Margin %	7.89%	5.48%	7.4%	8.85%	11.56%	12.04%	11.87%	8.79%	10.38%	10.47%
EBITDA Growth %	7.7%	-32.84%	48.05%	38.88%	54.09%	13.94%	13.5%	-8.75%	34.99%	19.71%
D&A (Non-Cash Add-back)	38.68M	44.47M	44.86M	51.05M	54.57M	55.98M	62.35M	72.39M	84.14M	104.33M
EBIT	92.95M	44.8M	86.93M	131.83M	226.97M	264.85M	298.02M	280.85M	394.38M	0
Net Interest Income+	-6.03M	-12.01M	-13.17M	-13.01M	-5.55M	-2.46M	-3.9M	11.13M	20.46M	0
Interest Income	1.11M	1.61M	2.02M	2.65M	3.81M	4.39M	5.04M	19.22M	28.75M	24.51M
Interest Expense	7.14M	13.62M	15.18M	15.66M	9.36M	6.85M	8.93M	8.09M	8.29M	-7.99M
Other Income/Expense	-6.03M	-12.01M	-13.17M	-13.01M	-5.55M	-2.46M	-7.74M	17.39M	27.79M	30.32M
Pretax Income+	85.82M	31.18M	71.75M	116.17M	217.61M	258M	289.09M	272.76M	386.09M	455.62M
Pretax Margin %	5.19%	1.95%	4.09%	5.7%	9.06%	9.82%	9.56%	7.31%	9.06%	9.01%
Income Tax+	32.98M	14.21M	12.69M	23.95M	46.24M	60.28M	64.44M	62.91M	87.64M	111.36M
Effective Tax Rate %	58.25%	129.81%	128.74%	95.15%	78.34%	75.45%	77.72%	76.77%	77.18%	75.49%
Net Income+	49.99M	40.48M	92.36M	110.53M	170.48M	194.65M	224.68M	209.4M	297.97M	343.97M
Net Margin %	3.02%	2.53%	5.26%	5.43%	7.1%	7.41%	7.43%	5.61%	6.99%	6.8%
Net Income Growth %	-9.82%	-19.03%	128.2%	19.67%	54.23%	14.18%	15.43%	-6.8%	42.3%	15.44%
Net Income (Continuing)	52.84M	16.97M	59.06M	92.21M	171.36M	197.72M	224.65M	209.85M	298.46M	344.26M
Discontinued Operations	0	23.7M	32.87M	18.84M	0	0	0	0	0	0
Minority Interest	4.05M	7.66M	11.4M	1.95M	150K	946K	1.47M	5.45M	3.32M	3.1M
EPS (Diluted)+	0.96	0.77	1.70	1.97	3.06	3.42	3.95	3.65	5.12	5.84
EPS Growth %	-9.43%	-19.79%	120.78%	15.88%	55.33%	11.76%	15.5%	-7.59%	40.27%	14.06%
EPS (Basic)	0.99	0.79	1.78	2.07	3.19	3.57	4.09	3.76	5.26	6.00
Diluted Shares Outstanding	52.13M	52.83M	54.4M	55.98M	55.79M	56.92M	56.87M	57.32M	58.24M	58.87M
Basic Shares Outstanding	50.55M	50.93M	52.02M	53.45M	53.43M	54.49M	54.89M	55.71M	56.66M	57.31M
Dividend Payout Ratio	16.35%	21.54%	10.2%	9.22%	6.35%	5.93%	5.42%	6.16%	4.59%	-

Balance Sheet

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Current Assets+	333.86M	368.08M	348.07M	411.08M	582.96M	639.71M	781.13M	1.05B	1.16B	1.27B
Cash & Short-Term Investments	69.26M	55.43M	39.77M	76.93M	250.01M	275.96M	331.71M	526.86M	526.85M	503.88M
Cash Only	57.71M	42.34M	31.08M	59.17M	236.56M	262.2M	316.27M	509.63M	464.6M	503.88M
Short-Term Investments	11.55M	13.09M	8.68M	17.75M	13.45M	13.76M	15.44M	17.23M	62.26M	0
Accounts Receivable	244.43M	265.07M	251.91M	308.99M	305.06M	328.73M	408.43M	485.04M	569.9M	636.99M
Days Sales Outstanding	53.91	60.53	52.4	55.38	46.34	45.67	49.27	47.47	48.82	45.97
Inventory	0	0	0	0	0	0	0	0	0	0
Days Inventory Outstanding	-	-	-	-	-	-	-	-	-	-
Other Current Assets	0	0	30.64M	0	0	29.56M	36.34M	35.04M	60.88M	131.44M
Total Non-Current Assets+	667.16M	734.36M	833.89M	1.95B	1.96B	2.21B	2.67B	3.13B	3.51B	4.19B
Property, Plant & Equipment	484.5M	537.08M	618.87M	1.81B	1.8B	2.03B	2.44B	2.85B	3.15B	3.79B
Fixed Asset Turnover	3.42x	2.98x	2.84x	1.12x	1.33x	1.30x	1.24x	1.31x	1.35x	1.33x
Goodwill	67.1M	81.06M	80.48M	54.47M	54.47M	60.47M	76.87M	76.87M	97.98M	97.98M
Intangible Assets	54.66M	58.05M	58.6M	6.45M	6.62M	6.38M	6.44M	6.53M	7.29M	6.38M
Long-Term Investments	0	0	0	0	0	0	0	0	0	166.84M
Other Non-Current Assets	37.83M	45.41M	130.75M	70.83M	65.36M	83.61M	104.94M	132.89M	187.75M	41.6M
Total Assets+	1B	1.1B	1.18B	2.36B	2.55B	2.85B	3.45B	4.18B	4.67B	5.46B
Asset Turnover	1.65x	1.45x	1.48x	0.86x	0.94x	0.92x	0.88x	0.89x	0.91x	0.93x
Asset Growth %	33.87%	10.13%	7.21%	99.83%	7.78%	11.98%	21.1%	21.02%	11.77%	17%
Total Current Liabilities+	211.93M	225.82M	269.23M	343.17M	562.4M	523.07M	582.07M	734.75M	743.43M	894.35M
Accounts Payable	38.99M	39.04M	39.85M	44.97M	50.9M	58.12M	77.09M	92.81M	98.95M	97.33M
Days Payables Outstanding	9.71	10	9.47	9.4	9.31	9.82	11.22	10.79	10.05	8.84
Short-Term Debt	8.13M	9.94M	10.11M	2.7M	2.96M	3.76M	3.88M	3.95M	4.09M	119.04M
Deferred Revenue (Current)	13.09M	13.64M	7.31M	10.69M	8.56M	9.34M	9.7M	10.83M	18.82M	0
Other Current Liabilities	1.97M	0	30.25M	0	102.02M	0	0	0	0	677.98M
Current Ratio	1.58x	1.63x	1.29x	1.20x	1.04x	1.22x	1.34x	1.42x	1.56x	1.42x
Quick Ratio	1.58x	1.63x	1.29x	1.20x	1.04x	1.22x	1.34x	1.42x	1.56x	1.42x
Cash Conversion Cycle	-	-	-	-	-	-	-	-	-	-
Total Non-Current Liabilities+	328.6M	376.55M	310.39M	1.36B	1.16B	1.31B	1.62B	1.95B	2.09B	2.33B
Long-Term Debt	275.49M	302.99M	233.13M	325.22M	112.54M	152.88M	149.27M	145.5M	141.59M	1.95B
Capital Lease Obligations	0	0	0	973.98M	950.32M	1.06B	1.36B	1.64B	1.74B	0
Deferred Tax Liabilities	0	0	0	0	0	0	0	0	0	0
Other Non-Current Liabilities	53.12M	61.49M	65.84M	63.39M	102.09M	96.44M	116.77M	160.65M	208.59M	384.59M
Total Liabilities	540.53M	602.37M	579.62M	1.71B	1.73B	1.83B	2.2B	2.68B	2.83B	3.23B
Total Debt+	283.62M	312.93M	243.24M	1.35B	1.11B	1.27B	1.57B	1.87B	1.97B	2.07B
Net Debt	225.91M	270.59M	212.16M	1.29B	877.45M	1B	1.26B	1.36B	1.51B	1.56B
Debt / Equity	0.62x	0.63x	0.40x	2.05x	1.36x	1.24x	1.26x	1.25x	1.07x	0.93x
Debt / EBITDA	2.17x	3.57x	1.87x	7.47x	4.01x	4.00x	4.38x	5.71x	4.46x	3.91x
Net Debt / EBITDA	1.73x	3.09x	1.63x	7.14x	3.16x	3.17x	3.50x	4.15x	3.41x	2.95x
Interest Coverage	12.87x	3.17x	5.59x	8.25x	23.84x	38.03x	33.24x	31.58x	43.24x	-
Total Equity+	460.5M	500.06M	602.34M	656.14M	818.23M	1.02B	1.25B	1.5B	1.84B	2.23B
Equity Growth %	7.85%	8.59%	20.45%	8.93%	24.7%	24.87%	22.23%	19.9%	22.92%	21.43%
Book Value per Share	8.83	9.47	11.07	11.72	14.67	17.95	21.96	26.12	31.60	37.96
Total Shareholders' Equity	456.45M	492.4M	590.93M	654.2M	818.08M	1.02B	1.25B	1.49B	1.84B	2.23B
Common Stock	52K	53K	55K	56K	58K	58K	59K	60K	61K	62K
Retained Earnings	235.02M	264.69M	344.9M	391.52M	551.05M	733.99M	946.34M	1.14B	1.43B	1.76B
Treasury Stock	-31.12M	-38.41M	-38.41M	-45.3M	-71.21M	-83.04M	-114.63M	-116.56M	-117.76M	0
Accumulated OCI	0	0	0	0	0	0	0	0	0	0
Minority Interest	4.05M	7.66M	11.4M	1.95M	150K	946K	1.47M	5.45M	3.32M	3.1M

Cash Flow

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Cash from Operations+	73.89M	72.95M	210.3M	192.22M	373.35M	275.68M	272.51M	376.67M	347.19M	564.27M
Operating CF Margin %	4.46%	4.56%	11.99%	9.44%	15.54%	10.49%	9.01%	10.1%	8.15%	11.16%
Operating CF Growth %	121.43%	-1.27%	188.27%	-8.6%	94.23%	-26.16%	-1.15%	38.22%	-7.83%	62.53%
Net Income	52.84M	40.83M	92.53M	111.69M	171.36M	197.72M	224.65M	209.85M	298.46M	344.26M
Depreciation & Amortization	38.68M	44.47M	47.34M	51.05M	54.57M	55.98M	62.35M	72.39M	84.14M	104.33M
Stock-Based Compensation	9.1M	9.7M	10.34M	11.32M	14.52M	18.68M	22.72M	30.77M	36.23M	48.3M
Deferred Taxes	-2.21M	10.33M	1.09M	3.49M	-27.81M	-24.88M	-6.5M	-27.48M	635K	-16.86M
Other Non-Cash Items	7.72M	32.51M	25.04M	10.72M	11.65M	28.14M	6.23M	53.25M	2.89M	84.24M
Working Capital Changes	-32.25M	-64.88M	33.96M	3.95M	149.05M	33K	-36.94M	37.89M	-75.16M	0
Change in Receivables	-63.62M	-52.3M	-13.1M	-60.42M	2.17M	-30.77M	-82.43M	-79.82M	-84.4M	-70.43M
Change in Inventory	30.3M	-9.8M	44.01M	55.62M	0	0	0	0	0	0
Change in Payables	577K	3.33M	3.08M	4.46M	6.63M	7.12M	17.87M	15.92M	2.83M	-2.92M
Cash from Investing+	-210.64M	-106.59M	-151.21M	-247.01M	-58.67M	-173.91M	-186.18M	-182.7M	-390.05M	-513.18M
Capital Expenditures	-65.7M	-54.08M	-135.62M	-71.54M	-50.33M	-69.55M	-87.55M	-106.18M	-158.24M	-193.56M
CapEx % of Revenue	3.97%	3.38%	7.73%	3.51%	2.09%	2.65%	2.89%	2.85%	3.71%	3.83%
Acquisitions	-23.58M	-77.51M	-4.72M	-6.46M	47.55M	-7.98M	-16.4M	0	0	0
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	-121.36M	23.41M	-526K	-165.54M	-58.67M	-91.6M	-74.62M	-64.55M	-153.06M	-308.57M
Cash from Financing+	152.88M	18.27M	-70.34M	82.88M	-137.3M	-76.14M	-32.26M	-612K	-2.16M	-11.81M
Debt Issued (Net)	184.49M	31.86M	-69.94M	83.35M	-212.54M	42.16M	-3.69M	-3.88M	-3.95M	0
Equity Issued (Net)	-1000K	-1000K	0	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K	0
Dividends Paid	-8.17M	-8.72M	-9.42M	-10.19M	-10.83M	-11.55M	-12.17M	-12.89M	-13.67M	-14.41M
Share Repurchases	-30M	-7.29M	-1.97M	-6.89M	-25.92M	-11.83M	-31.58M	-1.93M	-1.21M	-1.43M
Other Financing	6.57M	2.42M	9.01M	16.62M	111.99M	-94.92M	2.51M	18.09M	16.67M	2.6M
Net Change in Cash	16.14M	-15.37M	-11.25M	28.09M	177.39M	25.64M	54.07M	193.36M	-45.03M	39.28M
Free Cash Flow+	8.19M	15.79M	155.35M	120.68M	323.02M	206.13M	184.97M	270.49M	188.95M	370.71M
FCF Margin %	0.49%	0.99%	8.85%	5.93%	13.44%	7.85%	6.11%	7.25%	4.43%	7.33%
FCF Growth %	130.73%	92.77%	884.13%	-22.32%	167.67%	-36.19%	-10.27%	46.23%	-30.15%	96.2%
FCF per Share	0.16	0.30	2.86	2.16	5.79	3.62	3.25	4.72	3.24	6.30
FCF Conversion (FCF/Net Income)	1.48x	1.80x	2.28x	1.74x	2.19x	1.42x	1.21x	1.80x	1.17x	1.64x
Interest Paid	6.43M	13.28M	15.99M	0	9.92M	5.69M	7.6M	7.03M	7.06M	0
Taxes Paid	23.16M	38.38M	19.65M	0	74.36M	65.55M	70.06M	89.73M	96.34M	0

Key Ratios

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Return on Equity (ROE)	11.27%	8.43%	16.76%	17.57%	23.13%	21.16%	19.79%	15.25%	17.85%	16.88%
Return on Invested Capital (ROIC)	11.76%	4.45%	8.04%	7.02%	9.2%	10.5%	9.83%	7.14%	8.66%	8.92%
Gross Margin	11.39%	10.82%	12.46%	14.29%	16.96%	17.82%	17.12%	15.84%	15.67%	20.54%
Net Margin	3.02%	2.53%	5.26%	5.43%	7.1%	7.41%	7.43%	5.61%	6.99%	6.8%
Debt / Equity	0.62x	0.63x	0.40x	2.05x	1.36x	1.24x	1.26x	1.25x	1.07x	0.93x
Interest Coverage	12.87x	3.17x	5.59x	8.25x	23.84x	38.03x	33.24x	31.58x	43.24x	-
FCF Conversion	1.48x	1.80x	2.28x	1.74x	2.19x	1.42x	1.21x	1.80x	1.17x	1.64x
Revenue Growth	23.33%	-3.42%	9.78%	16.07%	17.98%	9.36%	15.15%	23.27%	14.24%	18.72%

The Ensign Group, Inc. (ENSG) 10-Year Financial Performance & Capital Metrics

Key Insights

✓Strengths

✗Weaknesses

Price & Volume

Growth Metrics

Revenue CAGR

Profit (Net Income) CAGR

EPS CAGR

ROCE

Peer Comparison

Compare ENSG vs Peers

vs EHC

vs BKD

Compare Top 5

Profit & Loss

Balance Sheet

Cash Flow

Key Ratios

Deep Dive Analysis

Valuation Overview

Total Return Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios

The Ensign Group, Inc. (ENSG) 10-Year Financial Performance & Capital Metrics

Key Insights

✓Strengths

✗Weaknesses

Price & Volume

Growth Metrics

Revenue CAGR

Profit (Net Income) CAGR

EPS CAGR

ROCE

Peer Comparison

Compare ENSG vs Peers

vs EHC

vs BKD

Compare Top 5

Profit & Loss

Balance Sheet

Cash Flow

Key Ratios

Deep Dive Analysis

Valuation Overview

Total Return Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios